Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Abatacept to Treat Refractory Sarcoidosis (STAR)
This study has been terminated.
( Funding has been pulled )
Study NCT00739960.   Last updated on December 22, 2008.
Information provided by University of Chicago
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sarcoidosis
More general conditions related to this trial
Lymphatic Diseases
Lymphoproliferative Disorders
Interventions listed in this trial
Abatacept
More general drug interventions related to this trial
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University of Chicago
Bristol-Myers Squibb


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services